Stryker, Johnson & Johnson and Zimmer Biomet posted their third-quarter financial results for 2025 and data on their spine orthopedic sales.
Here is how they compare:
Total sales: $6.1 billion (+10.3%)
Orthopedics: $2.3 billion (+3.9%)
Hips: $457 million (+8.9%)
Knees: $628 million (+10.2%)
Spine: $6 million
Net earnings: $859 million
Total sales: $2 billion (+9.7%)
Hips: $506.2 million (+5.1%)
Knees: $792.4 million (+6.3%)
Sports medicine, extremities, trauma, craniomaxillofacial and thoracic: $550.6 million (+17.3%)
Net earnings: $230.9 million
Medtech sales: $8.4 billion (+6.8%)
Orthopedic: $2.3 billion (+3.8%)
Spine, sports and other: $698 million (+0.3%)
Hips: $405 million (+6.4%)
Knees: $377 million (-17%)
Net earnings: $5.1 billion
